Is parenteral levothyroxine therapy safe in intractable hypothyroidism?

dc.contributor.authorPeynirci, Hande
dc.contributor.authorTaşkıran, Bengür
dc.contributor.buuauthorErtürk, Erdinç
dc.contributor.buuauthorŞişman, Pınar
dc.contributor.buuauthorErsoy, Canan
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji ve Metabolik Bozukluklar Anabilim Dalı.tr_TR
dc.contributor.researcheridAAJ-6536-2021tr_TR
dc.contributor.researcheridAAH-8861-2021tr_TR
dc.contributor.scopusid7005488796tr_TR
dc.contributor.scopusid57190169474tr_TR
dc.contributor.scopusid6701485882tr_TR
dc.date.accessioned2023-10-04T08:12:54Z
dc.date.available2023-10-04T08:12:54Z
dc.date.issued2018-06
dc.description.abstractCase: A 32-year old woman was admitted to the hospital due to intractable hypothyroidism refractory to high dose of oral L-thyroxine therapy. She underwent total thyroidectomy and radioactive iodine therapy due to papillary thyroid cancer. After excluding poor adherence to therapy and malabsorption, levothyroxine absorption test was performed. No response was detected. Transient neurologic symptoms developed during the test. She developed 3 attacks consisting of neurologic symptoms during high dose administration. The patient was considered a case of isolated L-thyroxine malabsorption. She became euthyroid after intramuscular twice weekly L-thyroxine therapy. Discussion: There are a few case reports regarding isolated L-thyroxine. We report successful long term results of twice weekly administered intramuscular L-thyroxine therapy. We also draw attention to neurologic side effects of high dose L-thyroxine therapy.en_US
dc.identifier.citationPeynirci, H. vd. (2018). ''Is parenteral levothyroxine therapy safe in intractable hypothyroidism?''. Journal of the National Medical Association, 110(3), 245-249.en_US
dc.identifier.endpage249tr_TR
dc.identifier.issn0027-9684
dc.identifier.issn1943-4693
dc.identifier.issue3tr_TR
dc.identifier.pubmed29778126tr_TR
dc.identifier.scopus2-s2.0-85020916109tr_TR
dc.identifier.startpage245tr_TR
dc.identifier.urihttps://doi.org/10.1016/j.jnma.2017.05.007
dc.identifier.urihttps://www.sciencedirect.com/science/article/abs/pii/S0027968417300287
dc.identifier.urihttp://hdl.handle.net/11452/34195
dc.identifier.volume110tr_TR
dc.identifier.wos000432909100008tr_TR
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherNatl Med Assocen_US
dc.relation.collaborationSanayitr_TR
dc.relation.journalJournal of the National Medical Associationen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGeneral & internal medicineen_US
dc.subjectHypothyroidismen_US
dc.subjectLevothyroxineen_US
dc.subjectMalabsorptionen_US
dc.subjectNeurologic manifestationsen_US
dc.subjectThyroxine absorptionen_US
dc.subjectPseudomalabsorptionen_US
dc.subjectMalabsorptionen_US
dc.subjectReplacementen_US
dc.subjectPatienten_US
dc.subjectDiseaseen_US
dc.subject.emtreeAcetylsalicylic aciden_US
dc.subject.emtreeLevothyroxineen_US
dc.subject.emtreeLiothyronineen_US
dc.subject.emtreeThyrotropinen_US
dc.subject.emtreeThyroxineen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAphasiaen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBlood pressureen_US
dc.subject.emtreeBody massen_US
dc.subject.emtreeBody temperatureen_US
dc.subject.emtreeBody weight gainen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeClinical articleen_US
dc.subject.emtreeDrug megadoseen_US
dc.subject.emtreeDrug safetyen_US
dc.subject.emtreeDry skinen_US
dc.subject.emtreeFatigueen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFree thyroxine indexen_US
dc.subject.emtreeHeart rateen_US
dc.subject.emtreeHemiparesisen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHypertensionen_US
dc.subject.emtreeHypothyroidismen_US
dc.subject.emtreeMenstruationen_US
dc.subject.emtreePhysical examinationen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreeSide effecten_US
dc.subject.emtreeThyroid function testen_US
dc.subject.emtreeThyrotropin blood levelen_US
dc.subject.emtreeTransient ischemic attacken_US
dc.subject.emtreeTreatment responseen_US
dc.subject.emtreeVisual impairmenten_US
dc.subject.emtreeHypothyroidismen_US
dc.subject.emtreeIntestine absorptionen_US
dc.subject.emtreeIntramuscular drug administrationen_US
dc.subject.emtreeMalabsorptionen_US
dc.subject.emtreeMetabolismen_US
dc.subject.emtreeOral drug administrationen_US
dc.subject.emtreePathologyen_US
dc.subject.emtreePathophysiologyen_US
dc.subject.emtreeProceduresen_US
dc.subject.emtreeThyroid tumoren_US
dc.subject.emtreeThyroidectomyen_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.meshAdministration, oralen_US
dc.subject.meshAdulten_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshHypothyroidismen_US
dc.subject.meshInjections, intramuscularen_US
dc.subject.meshIntestinal absorptionen_US
dc.subject.meshMalabsorption syndromesen_US
dc.subject.meshThyroid cancer, papillaryen_US
dc.subject.meshThyroid neoplasmsen_US
dc.subject.meshThyroidectomyen_US
dc.subject.meshThyroxineen_US
dc.subject.meshTreatment outcomeen_US
dc.subject.scopusLevothyroxine Sodium; Hypothyroidism; Thyrotropinen_US
dc.subject.wosMedicine, general & internalen_US
dc.titleIs parenteral levothyroxine therapy safe in intractable hypothyroidism?en_US
dc.typeArticle
dc.wos.quartileQ4en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: